{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:16:47Z","timestamp":1793143007887,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cystic Fibrosis Transmembrane Regulator (CFTR) is a significant protein that is responsible for the movement of ions across cell membranes. The cystic fibrosis (CF) occur due to the mutations in the <jats:italic>CFTR<\/jats:italic> gene as it produces the dysfunctional CFTR protein. The sequence of CFTR protein as a target structure was retrieved from UniProt and PDB database. The ligands selection was performed through virtual screening and top 3 ligands choose out of 65 ligands silibinins, curcumin, demethoxycurcumin were selected with a reference drug Trikafta (R*). According to docking, ADMET analyses, the natural ligands (Silibinins and Curcumin) displayed best binding energy, pharmacokinetic and free toxicity than other natural compounds and reference drug (R*). An MD simulation for 200\u00a0ns was also established to ensure that natural ligands (Silibinins and Curcumin) attached to the target protein favorably and dynamically, and that protein\u2013ligand complex stability was maintained. It is concluded that silibinins and curcumins have a better capacity to decrease the effect of mutant CFTR protein through improved trafficking and the restoration of original function. In conclusion, in silico studies demonstrate the potential of silibinins and curcumin as therapeutic agents for cystic fibrosis, particularly for the D614G mutated protein. Their ability to increase CFTR function while reducing cellular stress and inflammation, together with their favorable safety profile and accessibility could make them valuable additions to cystic fibrosis treatment options. Further experimental and clinical validation will be required to fully realize their potential and include them into effective therapy regimens.<\/jats:p>","DOI":"10.1186\/s13568-024-01742-z","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T16:10:40Z","timestamp":1721751040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Silibinins and curcumin as promising ligands against mutant cystic fibrosis transmembrane regulator protein"],"prefix":"10.1186","volume":"14","author":[{"given":"Areeba","family":"Akram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Sakhawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usman","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raima","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3160-4830","authenticated-orcid":false,"given":"Qurban","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jin-liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoud","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"1742_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.54112\/bbasr.v2021i1.36","volume":"2021","author":"A Abbas","year":"2021","unstructured":"Abbas A, Rehman A, Javed M (2021) Exploring the potential of in vitro tissue culture in breeding programs of legume and pulse crops: utilization and present condition. Bull Biol Allied Sci Res 2021:36\u201336","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248\u2013249","journal-title":"Nat Methods"},{"key":"1742_CR3","first-page":"437","volume":"9","author":"A Ashraf","year":"2023","unstructured":"Ashraf A, Ghani MU, Khan MU, Hassan HM, Mehdi Z (2023a) Personalized medicine; a potential therapy for cystic fibrosis. Adv Life Sci 9:437\u2013445","journal-title":"Adv Life Sci"},{"key":"1742_CR4","first-page":"437","volume":"9","author":"A Ashraf","year":"2023","unstructured":"Ashraf A, Ghani MU, Khan MU, Rehman HM (2023) Personalized medicine; a potential therapy for cystic fibrosis. Adv Life Sci 9:437\u2013445","journal-title":"Adv Life Sci"},{"key":"1742_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.54112\/bbasr.v2024i1.60","volume":"2024","author":"SJ Awan","year":"2024","unstructured":"Awan SJ, Fatima Z, Kamran S, Khan AS, Fatima T, Imran S, Shabbir M, Nadeem SI (2024) Guar gum in therapeutics: a succinct exploration. Bull Biol Allied Sci Res 2024:60","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR6","doi-asserted-by":"crossref","unstructured":"H Baharara P Kesharwani TP Johnston AJB Sahebkar 2023 Therapeutic potential of phytochemicals for cystic fibrosis 49 984 1009","DOI":"10.1002\/biof.1960"},{"key":"1742_CR7","doi-asserted-by":"crossref","unstructured":"Bradbury. (2020). Channels ICI, Health ToEi, 3 D-V (2020) CFTR and cystic fibrosis: a need for personalized medicine. 547\u2013604","DOI":"10.1007\/978-3-030-55454-5_15"},{"key":"1742_CR8","doi-asserted-by":"crossref","unstructured":"Brindha M, Shelishiyah R, Vasanthavalli S (2020) Molecular Docking analysis Of CFTR Inhibitors. In 2020 Sixth International Conference on Bio Signals, Images, and Instrumentation (ICBSII). IEEE, pp 1\u20134","DOI":"10.1109\/ICBSII49132.2020.9167624"},{"key":"1742_CR9","doi-asserted-by":"publisher","first-page":"W306","DOI":"10.1093\/nar\/gki375","volume":"33","author":"E Capriotti","year":"2005","unstructured":"Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2. 0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:W306\u2013W310","journal-title":"Nucleic Acids Res"},{"key":"1742_CR10","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/prot.20810","volume":"62","author":"J Cheng","year":"2006","unstructured":"Cheng J, Randall A, Baldi P (2006) Prediction of protein stability changes for single-site mutations using support vector machines. proteins: structure. Funct Bioinform 62:1125\u20131132","journal-title":"Funct Bioinform"},{"key":"1742_CR11","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi Y, Chan AP (2015) PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 31:2745\u20132747","journal-title":"Bioinformatics"},{"key":"1742_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev.genom.6.080604.162254","volume":"6","author":"GR Cutting","year":"2005","unstructured":"Cutting GR (2005) Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 6:237\u2013260","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1742_CR13","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"},{"key":"1742_CR14","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1093\/bioinformatics\/btx521","volume":"33","author":"G Del\u00e9age","year":"2017","unstructured":"Del\u00e9age G (2017) ALIGNSEC: viewing protein secondary structure predictions within large multiple sequence alignments. Bioinformatics 33:3991\u20133992","journal-title":"Bioinformatics"},{"key":"1742_CR15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4187\/aarc0443","volume":"54","author":"PA Flume","year":"2009","unstructured":"Flume PA, Robinson KA, O\u2019Sullivan BP, Finder JD, Vender RL, Willey-Courand D-B, White TB, Marshall BC (2009) Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 54:522\u2013537","journal-title":"Respir Care"},{"key":"1742_CR16","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger E, Gattiker A, Hoogland C, Ivanyi I, Appel RD, Bairoch A (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31:3784\u20133788","journal-title":"Nucleic Acids Res"},{"key":"1742_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461","journal-title":"Expert Opin Drug Discov"},{"key":"1742_CR18","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.genrep.2021.101127","volume":"23","author":"P Ghosh","year":"2021","unstructured":"Ghosh P, Ghosh S, Behera B, Behera JK, Bhattacharya M (2021) In-silico analysis of non-synonymous SNPs of human LDLR gene and their impact on familial hypercholesterolemia. Gene Rep 23:101127","journal-title":"Gene Rep"},{"key":"1742_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.54112\/bbasr.v2023i1.49","volume":"2023","author":"N Hassan","year":"2023","unstructured":"Hassan N, Amin F, Bashir K, Irshad M, Jamil S, Munawar N, Haqqani H, Shabir H, Khan M (2023) Antiviral response of drugs used against hbv patients of Khyber Pakhtunkhwa, Pakistan. Bull Biol Allied Sci Res 2023:49\u201349","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jcf.2021.10.002","volume":"21","author":"S Heo","year":"2022","unstructured":"Heo S, Young DC, Safirstein J, Bourque B, Antell MH, Diloreto S, Rotolo (2022) Mental status changes during elexacaftor\/tezacaftor\/ivacaftor therapy. J Cystic Fibrosis. 21:339\u2013343","journal-title":"J Cystic Fibrosis."},{"key":"1742_CR21","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.3390\/app13106045","volume":"13","author":"D Iacopetta","year":"2023","unstructured":"Iacopetta D, Ceramella J, Catalano A, Scali E, Scumaci D, Pellegrino M, Aquaro S, Saturnino C, Sinicropi MSJAS (2023) Impact of cytochrome P450 enzymes on the phase I metabolism of drugs. Appl Sci 13:6045","journal-title":"Appl Sci"},{"issue":"45606","key":"1742_CR22","first-page":"45615","volume":"8","author":"M Iazzi","year":"2023","unstructured":"Iazzi M, Junor P, Doshi J, Acharya S, S\u00fchring R, Viirre RD (2023) Synthesis and evaluation of ivacaftor derivatives with reduced lipophilicity. ACS omega 8(45606):45615","journal-title":"ACS omega"},{"key":"1742_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/157340607780059521","volume":"3","author":"SA Khedkar","year":"2007","unstructured":"Khedkar SA, Malde AK, Coutinho EC, Srivastava S (2007) Pharmacophore modeling in drug discovery and development: an overview. Med Chem 3:187\u2013197","journal-title":"Med Chem"},{"key":"1742_CR24","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1021\/acs.jcim.0c00326","volume":"60","author":"S Kumar","year":"2020","unstructured":"Kumar S, Sharma PP, Shankar U, Kumar D, Joshi SK, Pena L, Durvasula R, Kumar A, Kempaiah P, Poonam, (2020) Discovery of new hydroxyethylamine analogs against 3CLpro protein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation, and structure\u2013activity relationship studies. J Chem Inf Model 60:5754\u20135770","journal-title":"J Chem Inf Model"},{"key":"1742_CR25","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/bioinformatics\/btv769","volume":"32","author":"J Laimer","year":"2016","unstructured":"Laimer J, Hiebl-Flach J, Lengauer D, Lackner P (2016) MAESTROweb: a web server for structure-based protein stability prediction. Bioinformatics 32:1414\u20131416","journal-title":"Bioinformatics"},{"key":"1742_CR26","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1093\/bioinformatics\/btp528","volume":"25","author":"B Li","year":"2009","unstructured":"Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD, Radivojac P (2009) Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25:2744\u20132750","journal-title":"Bioinformatics"},{"key":"1742_CR27","doi-asserted-by":"publisher","first-page":"116155","DOI":"10.1016\/j.biopha.2024.116155","volume":"171","author":"D Li","year":"2024","unstructured":"Li D, Zhu Y, Donnelley M, Parsons D, Habgood MD (2024) Fetal drug exposure after maternally administered CFTR modulators Elexacaftor\/Tezacaftor\/Ivacaftor in a rat model. Biomed Pharmacother 171:116155","journal-title":"Biomed Pharmacother"},{"issue":"897","key":"1742_CR28","first-page":"913","volume":"16","author":"M Lopes-Pacheco","year":"2021","unstructured":"Lopes-Pacheco M, Pedemonte N (2021) Discovery of CFTR modulators for the treatment of cystic fibrosis. ERJ Open Res 16(897):913","journal-title":"ERJ Open Res"},{"issue":"D1","key":"1742_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/nar\/gkaa913","volume":"49","author":"J Mistry","year":"2021","unstructured":"Mistry J, Chuguransky S, Williams L, Qureshi M, Salazar G, Sonnhammer E, Tosatto S, Paladin L, Raj S, Richardson L (2021) Pfam: the protein families database in 2021: nucleic acids research. Nucl Acids Res 49(D1):412\u2013419","journal-title":"Nucl Acids Res"},{"key":"1742_CR30","volume-title":"Analysis of expanded carrier screening panels for use in UPMC primary care clinics","author":"G Mitrick","year":"2023","unstructured":"Mitrick G (2023) Analysis of expanded carrier screening panels for use in UPMC primary care clinics. University of Pittsburgh, Pittsburgh"},{"key":"1742_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.54112\/bbasr.v2024i1.68","volume":"2024","author":"K Nawaz","year":"2024","unstructured":"Nawaz K, Khan S, Bibi A (2024) Insights into scabies prevalence and risk factors. Bull Biol Allied Sci Res 2024:68","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2142\/biophysico.15.0_33","volume":"15","author":"M Odera","year":"2018","unstructured":"Odera M, Furuta T, Sohma Y, Sakurai M (2018) Molecular dynamics simulation study on the structural instability of the most common cystic fibrosis-associated mutant \u0394F508-CFTR. Biophys Physicobiol 15:33\u201344","journal-title":"Biophys Physicobiol"},{"key":"1742_CR33","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1038\/s41467-020-19669-x","volume":"11","author":"V Pejaver","year":"2020","unstructured":"Pejaver V, Urresti J, Lugo-Martinez J, Pagel KA, Lin GN, Nam H-J, Mort M, Cooper DN, Sebat J, Iakoucheva LM (2020) Inferring the molecular and phenotypic impact of amino acid variants with MutPred2. Nat Commun 11:5918","journal-title":"Nat Commun"},{"key":"1742_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.54112\/bbasr.v2021i1.32","volume":"2021","author":"B Pervaiz","year":"2021","unstructured":"Pervaiz B, Hassan N, Fazal M, Mohammad Z, Munawar N, Ullah Z, Haqqani S, Zia T, Ullah A (2021) Comparative analysis of different pathogenic microbe collected from mammalian milk. Bull Biol Allied Sci Res 2021:32\u201332","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR35","doi-asserted-by":"publisher","first-page":"W314","DOI":"10.1093\/nar\/gku411","volume":"42","author":"DE Pires","year":"2014","unstructured":"Pires DE, Ascher DB, Blundell TL (2014) DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res 42:W314\u2013W319","journal-title":"Nucleic Acids Res"},{"key":"1742_CR36","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.3390\/ijms25063384","volume":"25","author":"Y Ramananda","year":"2024","unstructured":"Ramananda Y, Naren AP, Arora KJ (2024) Functional consequences of CFTR interactions in cystic fibrosis. Int J Mol Sci 25:3384","journal-title":"Int J Mol Sci"},{"key":"1742_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13568-023-01640-w","volume":"13","author":"A Sakhawat","year":"2023","unstructured":"Sakhawat A, Khan MU, Rehman R, Khan S, Shan MA, Batool A, Javed MA, Ali QJAE (2023) Natural compound targeting BDNF V66M variant: insights from in silico docking and molecular analysis. AMB Express 13:134","journal-title":"AMB Express"},{"key":"1742_CR38","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","volume":"31","author":"T Schwede","year":"2003","unstructured":"Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31:3381\u20133385","journal-title":"Nucleic Acids Res"},{"key":"1742_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13568-024-01664-w","volume":"14","author":"MA Shan","year":"2024","unstructured":"Shan MA, Khan MU, Ishtiaq W, Rehman R, Khan S, Javed MA, Ali QJ (2024) In silico analysis of the Val66Met mutation in BDNF protein: implications for psychological stress. AMB Express 14:11","journal-title":"AMB Express"},{"key":"1742_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.54112\/bbasr.v2024i1.71","volume":"2024","author":"BK Sheema","year":"2024","unstructured":"Sheema BK, Fiaz S, Khan AW, Haqqani S, Bibi A, Nawaz K, Khan MA, Ullah A (2024) Molecular identification of hcv genotypes among injecting drug users having HCV and HIV co-infection. Bull Biol Allied Sci Research 2024:71","journal-title":"Bull Biol Allied Sci Research"},{"key":"1742_CR41","doi-asserted-by":"publisher","first-page":"426a","DOI":"10.1016\/j.bpj.2023.11.2583","volume":"123","author":"A Sierra","year":"2024","unstructured":"Sierra A, Brini E (2024) Prediction of protein stability changes upon mutation using MELD\u00d7 MD. Biophys J 123:426a","journal-title":"Biophys J"},{"issue":"2031","key":"1742_CR42","first-page":"526098","volume":"2001","author":"B Sipione","year":"2023","unstructured":"Sipione B, Lor\u00e8 NI, Sanvito F, Rossi G, Neri A, Gianferro F, Tascini AS, Livraghi-Butrico A, Cigana C, Bragonzi A (2023) \u0394F508-Cftr mutation in genetically diverse Collaborative Cross mice yields novel disease-relevant phenotypes for cystic fibrosis. bioRxiv 2001(2031):526098","journal-title":"bioRxiv"},{"key":"1742_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010966.pub3","author":"KW Southern","year":"2020","unstructured":"Southern KW, Murphy J, Sinha IP, Nevitt SJ (2020) Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del). Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010966.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1742_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.54112\/bbasr.v2023i1.42","volume":"2023","author":"I Ullah","year":"2023","unstructured":"Ullah I, Ullah A, Rehman S, Ullah S, Ullah H, Haqqni S, Amir M, Gul F, Bashir K (2023a) Prevalence and risk factors of helicobacter pylori infection among individuals with tobacco consumption habits in district Peshawar: a cross-sectional study. Bull Biol Allied Sci Res 2023:42\u201342","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.54112\/bbasr.v2023i1.34","volume":"2023","author":"W Ullah","year":"2023","unstructured":"Ullah W, Ullah A, Khan M, Hassan N, Aman K, Khan S, Hassan S, Hazrat A (2023b) Microbial profile and nutritional evaluation of broiler and domestic chicken meat from selected districts of Khyber Pakhtunkhwa, Pakistan. Bull Biol Allied Sci Res 2023:34\u201334","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.54112\/bbasr.v2024i1.64","volume":"2024","author":"A Ullah","year":"2024","unstructured":"Ullah A, Bibi A, Ullah I, Kayani REZ, Asim M, Munawar N, Amjad M, Siraj M, Gohar M, Khan MA (2024) An overview of hepatitis c virus and liver cirrhosis in pakistan. Bull Biol Allied Sci Res 2024:64","journal-title":"Bull Biol Allied Sci Res"},{"key":"1742_CR47","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","volume":"27","author":"G Veit","year":"2016","unstructured":"Veit G, Avramescu RG, Chiang AN, Houck SA, Cai Z, Peters KW, Hong JS, Pollard HB, Guggino WB, Balch WE (2016) From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations. Mol Biol Cell 27:424\u2013433","journal-title":"Mol Biol Cell"},{"key":"1742_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-548","volume":"11","author":"H Venselaar","year":"2010","unstructured":"Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G (2010) Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinform 11:1\u201310","journal-title":"BMC Bioinform"},{"key":"1742_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1085\/jgp.20028673","volume":"121","author":"P Vergani","year":"2003","unstructured":"Vergani P, Nairn AC, Gadsby DC (2003) On the mechanism of MgATP-dependent gating of CFTR Cl\u2212 channels. J Gen Physiol 121:17\u201336","journal-title":"J Gen Physiol"},{"key":"1742_CR50","doi-asserted-by":"publisher","first-page":"W140","DOI":"10.1093\/nar\/gkaa275","volume":"48","author":"D Wang","year":"2020","unstructured":"Wang D, Liu D, Yuchi J, He F, Jiang Y, Cai S, Li J, Xu D (2020) MusiteDeep: a deep-learning based webserver for protein post-translational modification site prediction and visualization. Nucleic Acids Res 48:W140\u2013W146","journal-title":"Nucleic Acids Res"},{"key":"1742_CR51","doi-asserted-by":"publisher","first-page":"W215","DOI":"10.1093\/nar\/gkr363","volume":"39","author":"CL Worth","year":"2011","unstructured":"Worth CL, Preissner R, Blundell TL (2011) SDM\u2014a server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res 39:W215\u2013W222","journal-title":"Nucleic Acids Res"},{"key":"1742_CR52","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1440-1681.2008.04943.x","volume":"35","author":"LN Xu","year":"2008","unstructured":"Xu LN, Na WL, Liu X, Hou SG, Lin S, Yang H, Ma THJC (2008) Identification of natural coumarin compounds that rescue defective \u0394F508-CFTR chloride channel gating. Clin Experim Pharmacol Physiol 35:878\u2013883","journal-title":"Clin Experim Pharmacol Physiol"},{"key":"1742_CR53","volume-title":"Application of molecular docking in studies on the binding mechanism of three enzymes with natural products applied case studies and solutions in molecular docking-based drug design","author":"H-j Zeng","year":"2016","unstructured":"Zeng H-j, Yang R, Qu L-b (2016) Application of molecular docking in studies on the binding mechanism of three enzymes with natural products applied case studies and solutions in molecular docking-based drug design. IGI Global, Hershey"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-024-01742-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-024-01742-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-024-01742-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T17:09:19Z","timestamp":1721754559000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-024-01742-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1742"],"URL":"https:\/\/doi.org\/10.1186\/s13568-024-01742-z","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal and human participants were involved in this study and the current research project was approved by the institutional ethical review board of Precision Genomics Research Lab, Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}